Addressing overtreatment following the diagnosis of localized prostate cancer

Expert Rev Anticancer Ther. 2016;16(4):373-4. doi: 10.1586/14737140.2016.1143779. Epub 2016 Feb 12.

Authors

Thomas Tawadros¹, Massimo Valerio^{1

2

3}

Affiliations

¹ a Department of Urology , Centre Hospitalier Universitaire Vaudois , Lausanne , Switzerland.
² b Department of Urology , University College London Hospitals NHS Foundation Trust , London , UK.
³ c Division of Surgery and Interventional Science , University College London , London , UK.

PMID: 26776104
DOI: 10.1586/14737140.2016.1143779

No abstract available

Publication types

Editorial

MeSH terms

Humans
Male
Mass Screening
Medical Overuse*
Prostate-Specific Antigen / analysis
Prostatic Neoplasms / diagnosis*
Prostatic Neoplasms / therapy*

Substances

Prostate-Specific Antigen